| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 48 |
| 1 | TACROLIMUS | 47 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 45 |
| 3 | TACROLIMUS OINTMENT 0.1% | 45 |
| 4 | PANTOPRAZOLE | 43 |
| 5 | ADALIMUMAB | 38 |
| 6 | ASPIRIN | 38 |
| 7 | PREDNISONE | 38 |
| 8 | ACETAMINOPHEN 500MG | 37 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 37 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 18 | 0.0023 |
| 1 | DICLOFENAC SODIUM AND MISOPROSTOL | 11 | 0.0017 |
| 2 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 8 | 0.0011 |
| 3 | SIROLIMUS | 13 | 0.0010 |
| 4 | RITONAVIR 100 MG | 14 | 0.0009 |
| 5 | ERGOCALCIFEROL | 24 | 0.0008 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 6 | 0.0007 |
| 7 | LAMIVUDINE | 16 | 0.0006 |
| 8 | KETOPROFEN | 7 | 0.0005 |
| 9 | GOLIMUMAB | 6 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 89 |
| 1 | Corticosteroid [EPC] | 81 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 38 |
| 3 | Proton Pump Inhibitor [EPC] | 38 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 5 | Benzodiazepine [EPC] | 27 |
| 6 | Vitamin C [EPC] | 26 |
| 7 | Provitamin D2 Compound [EPC] | 24 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 23 |
| 9 | Osmotic Laxative [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Provitamin D2 Compound [EPC] | 24 | 0.0008 |
| 3 | Prostaglandin E1 Analog [EPC] | 12 | 0.0007 |
| 4 | Pyrethroid [EPC] | 1 | 0.0006 |
| 5 | Protease Inhibitor [EPC] | 23 | 0.0005 |
| 6 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0004 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 23 | 0.0004 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 5 | 0.0004 |